HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davreux, C. J. Articles by Patterson, G. A. Search for Related Content PubMed PubMed Citation Articles by Davreux, C. J. Articles by Patterson, G. A.

The Annals of Thoracic Surgery, Vol 55, 131-134, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Improved tracheal allograft viability in immunosuppressed rats

CJ Davreux, NH Chu, TK Waddell, E Mayer and GA Patterson
Department of Surgery, University of Toronto, Ontario, Canada.

Airway ischemia has been a common cause of morbidity and mortality in clinical lung transplantation. The present study examined the effects of cyclosporin A (CsA) and methylprednisolone (MP) on the viability of the devascularized trachea after heterotopic transplantation and omentopexy. Thirty-six tracheal segments were harvested from 18 donor Lewis rats, wrapped in omentum, and heterotopically implanted into the abdomen of recipient rats. Tracheal segments were randomly allocated into one of six recipient groups (n = 6): Lewis syngeneic controls, and five groups of Brown Norway recipients, receiving either no treatment, CsA alone (5 mg.kg-1.day-1 or 15 mg.kg-1.day-1), or CsA in combination with MP (5 mg CsA + 1 mg MP per kg/day or 15 mg CsA + 2 mg MP per kg/day, respectively). After 14 days, the tracheal segments were histologically evaluated. Epithelial thickness and the degree of epithelial regeneration were significantly different (p < 0.05) between the syngeneic control group and the untreated Brown Norway group. Without immunosuppression there was virtually no epithelium, whereas low-dose immunosuppression yielded intermediate viability, and with high dose CsA and MP we observed improved tracheal viability. In this high-dose group, the epithelium was thicker than in even the syngeneic control group. These results indicate that, in heterotopic tracheal allografts, viability may be improved with an optimum combination of CsA and MP.

This article has been cited by other articles:

				A. Boehler and M. Estenne Post-transplant bronchiolitis obliterans Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018. [Abstract] [Full Text] [PDF]

				H. C. Grillo Tracheal replacement: a critical review Ann. Thorac. Surg., June 1, 2002; 73(6): 1995 - 2004. [Abstract] [Full Text] [PDF]

				Y. Liu, T. Nakamura, Y. Shimizu, H. Ueda, M. Yoshitani, T. Toba, and S. Fukuda Tracheal allotransplantation in beagle dogs without immunosuppressants Ann. Thorac. Surg., October 1, 2001; 72(4): 1190 - 1194. [Abstract] [Full Text] [PDF]

				Y. Liu, T. Nakamura, Y. Yamamoto, K. Matsumoto, T. Sekine, H. Ueda, and Y. Shimizu Immunosuppressant-free allotransplantation of the tracheaThe antigenicity of tracheal grafts can be reduced by removing the epithelium and mixed glands from the graft by detergent treatment J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 108 - 114. [Abstract] [Full Text] [PDF]

				R. Nakanishi and K. Yasumoto Minimal Dose of Cyclosporin A for Tracheal Allografts Ann. Thorac. Surg., September 1, 1995; 60(3): 635 - 639. [Abstract] [Full Text]

				P. R. Delaere, Z. Y. Liu, R. Hermans, R. Sciot, and L. Feenstra Experimental tracheal allograft revascularization and transplantation J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 728 - 737. [Abstract] [Full Text]